These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 30218581)

  • 1. A hyperactive mutant of interferon-regulatory factor 4.
    Kang CH; Hartmann E; Menke L; Staudenraus D; Abass EF; Raifer H; Porapu A; Camara B; Brüstle A; Pinkenburg O; Bieringer M; Lohoff M
    Eur J Immunol; 2019 May; 49(5):812-815. PubMed ID: 30218581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bach2 overexpression represses Th9 cell differentiation by suppressing IRF4 expression in systemic lupus erythematosus.
    Sheng Y; Zhang J; Li K; Wang H; Wang W; Wen L; Gao J; Tang X; Tang H; Huang H; Cai M; Yuan T; Liu L; Zheng X; Zhu Z; Cui Y
    FEBS Open Bio; 2021 Feb; 11(2):395-403. PubMed ID: 33249782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRF4 at the crossroads of effector T-cell fate decision.
    Huber M; Lohoff M
    Eur J Immunol; 2014 Jul; 44(7):1886-95. PubMed ID: 24782159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point mutation L116R in interferon-regulatory factor 4 differentially impacts key cytokine production in Th2, Th9, and Th17 cells.
    Staudenraus D; Porapu A; Leister H; Gupta DD; Lohoff M
    Eur J Immunol; 2022 Oct; 52(10):1680-1683. PubMed ID: 36047738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells.
    Staudt V; Bothur E; Klein M; Lingnau K; Reuter S; Grebe N; Gerlitzki B; Hoffmann M; Ulges A; Taube C; Dehzad N; Becker M; Stassen M; Steinborn A; Lohoff M; Schild H; Schmitt E; Bopp T
    Immunity; 2010 Aug; 33(2):192-202. PubMed ID: 20674401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad2/3 and IRF4 play a cooperative role in IL-9-producing T cell induction.
    Tamiya T; Ichiyama K; Kotani H; Fukaya T; Sekiya T; Shichita T; Honma K; Yui K; Matsuyama T; Nakao T; Fukuyama S; Inoue H; Nomura M; Yoshimura A
    J Immunol; 2013 Sep; 191(5):2360-71. PubMed ID: 23913959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of CD4+ and CD8+ T Cell Subsets and Interferon Regulatory Factor 4 (IRF4) in MS Patients Treated with Fingolimod (FTY-720): A Follow-up Study.
    Laribi B; Sahraian MA; Shekarabi M; Emamnejad R; Marzban M; Sadaghiani S; Izad M
    Iran J Allergy Asthma Immunol; 2018 Aug; 17(4):346-360. PubMed ID: 30537798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTORC2 controls Th9 polarization and allergic airway inflammation.
    Chen H; Zhang L; Wang P; Su H; Wang W; Chu Z; Zhang L; Zhang X; Zhao Y
    Allergy; 2017 Oct; 72(10):1510-1520. PubMed ID: 28273354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4.
    Campos Carrascosa L; Klein M; Kitagawa Y; Lückel C; Marini F; König A; Guralnik A; Raifer H; Hagner-Benes S; Rädler D; Böck A; Kang C; Lohoff M; Garn H; Schaub B; Berberich-Siebelt F; Sakaguchi S; Bopp T; Huber M
    Nat Commun; 2017 May; 8():15366. PubMed ID: 28497800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon Regulatory Factor 4 controls T
    Mahnke J; Schumacher V; Ahrens S; Käding N; Feldhoff LM; Huber M; Rupp J; Raczkowski F; Mittrücker HW
    Sci Rep; 2016 Oct; 6():35521. PubMed ID: 27762344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRF4 is required for migration of CD4
    Schmidt C; Harberts A; Reimers D; Bertram T; Voß LC; Schmid J; Lory NC; Spohn M; Koch-Nolte F; Huber S; Raczkowski F; Breloer M; Mittrücker HW
    Front Immunol; 2023; 14():1182502. PubMed ID: 37469513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A neomorphic mutation in the interferon activation domain of IRF4 causes a dominant primary immunodeficiency.
    Thouenon R; Chentout L; Moreno-Corona N; Poggi L; Lombardi EP; Hoareau B; Schmitt Y; Lagresle-Peyrou C; Bustamante J; André I; Cavazzana M; Durandy A; Casanova JL; Galicier L; Fadlallah J; Fischer A; Kracker S
    J Exp Med; 2023 Jun; 220(6):. PubMed ID: 36917008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itk is required for Th9 differentiation via TCR-mediated induction of IL-2 and IRF4.
    Gomez-Rodriguez J; Meylan F; Handon R; Hayes ET; Anderson SM; Kirby MR; Siegel RM; Schwartzberg PL
    Nat Commun; 2016 Mar; 7():10857. PubMed ID: 26936133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4.
    Brüstle A; Heink S; Huber M; Rosenplänter C; Stadelmann C; Yu P; Arpaia E; Mak TW; Kamradt T; Lohoff M
    Nat Immunol; 2007 Sep; 8(9):958-66. PubMed ID: 17676043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRF4 Has a Unique Role in Early B Cell Development and Acts Prior to CD21 Expression to Control Marginal Zone B Cell Numbers.
    Ottens K; Satterthwaite AB
    Front Immunol; 2021; 12():779085. PubMed ID: 34880871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRF4 regulates IL-10 gene expression in CD4(+) T cells through differential nuclear translocation.
    Lee CG; Hwang W; Maeng KE; Kwon HK; So JS; Sahoo A; Lee SH; Park ZY; Im SH
    Cell Immunol; 2011; 268(2):97-104. PubMed ID: 21440248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRF4 links antigen affinity to CD8+ T-cell metabolism.
    Finlay D
    Immunol Cell Biol; 2014 Jan; 92(1):6-7. PubMed ID: 24165980
    [No Abstract]   [Full Text] [Related]  

  • 18. Tc9 cells, a new subset of CD8(+) T cells, support Th2-mediated airway inflammation.
    Visekruna A; Ritter J; Scholz T; Campos L; Guralnik A; Poncette L; Raifer H; Hagner S; Garn H; Staudt V; Bopp T; Reuter S; Taube C; Loser K; Huber M
    Eur J Immunol; 2013 Mar; 43(3):606-18. PubMed ID: 23254356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlike αβ T cells, γδ T cells, LTi cells and NKT cells do not require IRF4 for the production of IL-17A and IL-22.
    Raifer H; Mahiny AJ; Bollig N; Petermann F; Hellhund A; Kellner K; Guralnik A; Reinhard K; Bothur E; Huber M; Bauer S; Löhning M; Kiss EA; Ganal SC; Diefenbach A; Korn T; Lohoff M
    Eur J Immunol; 2012 Dec; 42(12):3189-201. PubMed ID: 22961652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th9 Cells: Probable players in ulcerative colitis pathogenesis.
    Shohan M; Elahi S; Shirzad H; Rafieian-Kopaei M; Bagheri N; Soltani E
    Int Rev Immunol; 2018; 37(4):192-205. PubMed ID: 29672174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.